Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)

Clinical trial NCT02739997 · COMPLETED

Trial details

NCT number: NCT02739997
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Intra-abdominal Infection Complicated Intra-abdominal Infection

Start date: 2016-04-08
Primary completion: 2017-07-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.